Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Pulmonary Hypertension

  Free Subscription


22.04.2019

1 Am Heart J
1 Cell Prolif
1 Chest
1 Circulation
1 Clin Ther
1 Drug Deliv Transl Res
1 Echocardiography
1 Eur J Med Chem
1 Front Physiol
1 Heart Lung Circ
1 Indian J Nephrol
1 Intern Med
1 J Matern Fetal Neonatal Med
2 J Thorac Cardiovasc Surg
2 JACC Cardiovasc Interv
1 PLoS One
2 Pulm Circ
1 Pulm Pharmacol Ther
1 Scand J Clin Lab Invest
1 Ther Innov Regul Sci
2 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. ZWIJNENBURG RD, Baggen VJM, Geenen LW, Voigt KR, et al
    The prevalence of pulmonary arterial hypertension before and after atrial septal defect closure at adult age: A systematic review.
    Am Heart J. 2018;201:63-71.
    PubMed     Text format     Abstract available


    Cell Prolif

  2. LIU A, Liu Y, Li B, Yang M, et al
    Role of miR-223-3p in pulmonary arterial hypertension via targeting ITGB3 in the ECM pathway.
    Cell Prolif. 2019;52:e12550.
    PubMed     Text format     Abstract available


    Chest

  3. ALTSCHUL E, Remy-Jardin M, Machnicki S, Sulica R, et al
    Imaging of pulmonary hypertension: Pictorial essay.
    Chest. 2019 Apr 11. pii: S0012-3692(19)30826-8. doi: 10.1016/j.chest.2019.
    PubMed     Text format     Abstract available


    Circulation

  4. MARON BA, Ryan JJ
    A Concerning Trend for Patients With Pulmonary Hypertension in the Era of Evidence-Based Medicine.
    Circulation. 2019;139:1861-1864.
    PubMed     Text format    


    Clin Ther

  5. RHINE WD, Suzuki S, Potenziano JL, Escalante S, et al
    An Analysis of Time to Improvement in Oxygenation in Japanese Preterm and Late Preterm or Term Neonates With Hypoxic Respiratory Failure and Pulmonary Hypertension.
    Clin Ther. 2019 Apr 12. pii: S0149-2918(19)30123.
    PubMed     Text format     Abstract available


    Drug Deliv Transl Res

  6. DHOBLE S, Patravale V
    Development of anti-angiogenic erlotinib liposomal formulation for pulmonary hypertension: a QbD approach.
    Drug Deliv Transl Res. 2019 Apr 18. pii: 10.1007/s13346-019-00641.
    PubMed     Text format     Abstract available


    Echocardiography

  7. MENG H, Chandrasekaran K, Villarraga HR, Shah AA, et al
    Right and left ventricular interaction in pulmonary hypertension: Insight from velocity vector imaging.
    Echocardiography. 2019 Apr 15. doi: 10.1111/echo.14328.
    PubMed     Text format     Abstract available


    Eur J Med Chem

  8. LI L, Zhang W, Lin F, Lu X, et al
    Synthesis and biological evaluation of pyrazolo[3,4-b]pyridine-3-yl pyrimidine derivatives as sGC stimulators for the treatment of pulmonary hypertension.
    Eur J Med Chem. 2019;173:107-116.
    PubMed     Text format     Abstract available


    Front Physiol

  9. FOROUZAN O, Dinges E, Runo JR, Keevil JG, et al
    Exercise-Induced Changes in Pulmonary Artery Stiffness in Pulmonary Hypertension.
    Front Physiol. 2019;10:269.
    PubMed     Text format     Abstract available


    Heart Lung Circ

  10. KRISHNAN A, Markham R, Savage M, Wong YW, et al
    Right Heart Catheterisation: How To Do It.
    Heart Lung Circ. 2019;28:e71-e78.
    PubMed     Text format     Abstract available


    Indian J Nephrol

  11. MEHTA KS, Shirkande AK, Bhurke SP, Pajai AE, et al
    Pulmonary Hypertension in Various Stages of Chronic Kidney Disease in Indian Patients.
    Indian J Nephrol. 2019;29:95-101.
    PubMed     Text format     Abstract available


    Intern Med

  12. YOKOKAWA T, Sugimoto K, Nakazato K, Misaka T, et al
    Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension after Balloon Pulmonary Angioplasty.
    Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.2320.
    PubMed     Text format     Abstract available


    J Matern Fetal Neonatal Med

  13. FU L, Zhang X
    Correlation between changes in brain natriuretic peptide and echocardiographic features in persistent pulmonary hypertension of newborn.
    J Matern Fetal Neonatal Med. 2019 Apr 17:1-5. doi: 10.1080/14767058.2018.1543392
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  14. NOLY PE, Piquereau J, Coblence M, Ataam JA, et al
    Right ventricular mitochondrial respiratory function in a piglet model of chronic pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2019 Mar 15. pii: S0022-5223(19)30564.
    PubMed     Text format     Abstract available

  15. AUGOUSTIDES JG
    Commentary: Mitochondrial targets in the failing right ventricle-multiple opportunities to rescue the right heart in pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2019 Mar 21. pii: S0022-5223(19)30672.
    PubMed     Text format    


    JACC Cardiovasc Interv

  16. YAYLALI YT, Basarici I
    Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?
    JACC Cardiovasc Interv. 2019;12:799-800.
    PubMed     Text format    

  17. ZHANG H, Chen SL
    Reply: Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?
    JACC Cardiovasc Interv. 2019;12:800-801.
    PubMed     Text format    


    PLoS One

  18. COTTIN V, Avot D, Levy-Bachelot L, Baxter CA, et al
    Identifying chronic thromboembolic pulmonary hypertension through the French national hospital discharge database.
    PLoS One. 2019;14:e0214649.
    PubMed     Text format     Abstract available


    Pulm Circ

  19. BILLINGS CG, Lewis R, Hurdman JA, Condliffe R, et al
    Express: The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry.
    Pulm Circ. 2019 Apr 18:2045894019848649. doi: 10.1177/2045894019848649.
    PubMed     Text format    

  20. CASCINO T, McLaughlin VV, Richardson C, Behbahani-Nejad N, et al
    EXPRESS: Barriers to physical activity in patients with pulmonary hypertension.
    Pulm Circ. 2019 Apr 15:2045894019847895. doi: 10.1177/2045894019847895.
    PubMed     Text format    


    Pulm Pharmacol Ther

  21. YAO Y, Li H, Da X, He Z, et al
    SUMOylation of Vps34 by SUMO1 promotes phenotypic switching of vascular smooth muscle cells by activating autophagy in pulmonary arterial hypertension.
    Pulm Pharmacol Ther. 2019;55:38-49.
    PubMed     Text format     Abstract available


    Scand J Clin Lab Invest

  22. KRIECHBAUM SD, Wiedenroth CB, Hesse ML, Ajnwojner R, et al
    Development of renal function during staged balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.
    Scand J Clin Lab Invest. 2019 Apr 15:1-8. doi: 10.1080/00365513.2019.1601765.
    PubMed     Text format     Abstract available


    Ther Innov Regul Sci

  23. DAIZADEH I
    Pulmonary Arterial Hypertension: A Case Study in FDA Expedited Program Designations.
    Ther Innov Regul Sci. 2019;53:264-269.
    PubMed     Text format     Abstract available


    Transplant Proc

  24. ACAR S, Donmez G, Acar RD, Kavlak ME, et al
    Idiopathic Pulmonary Hypertension After Liver Transplantation.
    Transplant Proc. 2019 Feb 8. pii: S0041-1345(18)31722.
    PubMed     Text format     Abstract available

  25. ZHU S, Zhou M, Wei D, Yang H, et al
    Risk Analysis of Perioperative Death in Lung Transplant Patients With Severe Idiopathic Pulmonary Hypertension.
    Transplant Proc. 2019;51:875-879.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: